As of September 30, 2026, Acadia Healthcare Company, Inc. carries a market capitalization of 45.23B, placing it among publicly traded companies globally. Its enterprise value stands at 91.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 45.23B |
| Enterprise Value | 91.66B |
Acadia Healthcare Company, Inc.'s next confirmed earnings release is scheduled for March 1, 2027.
| Earnings Date | 3/1/2027 |
As of September 30, 2026, Acadia Healthcare Company, Inc. has 90.91M shares outstanding.
| Shares Outstanding | 90.91M |
These figures are as of September 30, 2026. The price-to-sales ratio is 0.73, and the price-to-book ratio stands at 1.24.
| PS Ratio | 0.73 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 4.13 |
| P/FCF Ratio | 10.67 |
| P/OCF Ratio | 10.62 |
These figures are as of September 30, 2026. The EV/Sales ratio of 1.49 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 91.66B versus a market cap of 45.23B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 1.49 |
As of September 30, 2026, Acadia Healthcare Company, Inc. maintains a current ratio of 1.60, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 111.20, indicating elevated leverage, while an interest coverage ratio of -4.79 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.60 |
| Quick Ratio | 1.31 |
| Debt / Equity | 111.20 |
| Debt / EBITDA | -3.45 |
| Interest Coverage | -4.79 |
Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. posted a negative return on equity (ROE) of -43.87, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -18.85, reflecting losses generated across the asset base. The company generates approximately 2.46M in revenue per employee across its workforce of 25,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 19.52 indicates how many times Acadia Healthcare Company, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -43.87 |
| Return on Assets (ROA) | -18.85 |
| Revenue Per Employee | 2.46M |
| Employee Count | 25,000.00 |
| Inventory Turnover | 19.52 |
Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. recorded 756.74M in income tax expense. The company reported a pretax loss of -19.50B and -20.37B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 756.74M |
As of the close on November 10, 2026, Acadia Healthcare Company, Inc.'s stock has gained approximately 93.99% over the past 52 weeks.
| 52-Week Price Change | 93.99% |
Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. generated 61.60B in revenue and converted that into -20.37B in net income, yielding earnings per share of -222.35. EBITDA reached -13.12B, while operating income came in at 6.02B.
| Revenue | 61.60B |
| Gross Profit | 59.40B |
| Operating Income | 6.02B |
| Pretax Income | -19.50B |
| Net Income | -20.37B |
| EBITDA | -13.12B |
| EBIT | -16.76B |
| Earnings Per Share (EPS) | -222.35 |
As of September 30, 2026, Acadia Healthcare Company, Inc. holds 2.95B in cash and equivalents against 45.23B in total debt, resulting in a net debt position of 39.53B. Total book value stands at 36.52B, with working capital of 5.95B providing operational flexibility.
| Cash & Cash Equivalents | 2.95B |
| Total Debt | 45.23B |
| Net Debt | 39.53B |
| Equity (Book Value) | 36.52B |
| Book Value Per Share | 401.71 |
| Working Capital | 5.95B |
Acadia Healthcare Company, Inc. produced 4.25B in operating cash flow over the twelve months ended September 30, 2026.
| Operating Cash Flow | 4.25B |
| Free Cash Flow | 4.25B |
| FCF Per Share | 46.84 |
Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. posted a gross margin of 96.43, reflecting its pricing power and cost economics. The operating margin of 9.77 and net profit margin of -33.07 provide insight into operational efficiency.
| Gross Margin | 96.43 |
| Operating Margin | 9.77 |
| Pretax Margin | -31.66 |
| Profit Margin | -33.07 |
| EBITDA Margin | -21.30 |
These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 9.37, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -1.49, meaning Acadia Healthcare Company, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -1.49 |
| FCF Yield | 9.37 |
Acadia Healthcare Company, Inc.'s most recent stock split took place on November 1, 2011 with a 4:1 split ratio.
| Last Split Date | 11/1/2011 |
| Split Ratio | 4:1 |
As of September 30, 2026, Acadia Healthcare Company, Inc. has an Altman Z-Score of 1.40, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.40 |